Departamento de Farmacobiología, Sede Sur del Centro de Investigación y Estudios Avanzados del IPN, Mexico DF, Mexico.
Epilepsia. 2010 Mar;51(3):432-7. doi: 10.1111/j.1528-1167.2009.02315.x. Epub 2009 Sep 16.
To evaluate the effects of high-frequency electrical stimulation (HFS) in both ventral hippocampi, alone and combined with a subeffective dose of antiepileptic drugs, during the status epilepticus (SE) induced by lithium-pilocarpine (LP).
Male Wistar rats, stereotactically implanted in both ventral hippocampi, were injected with pilocarpine (30 mg/kg, i.p.) 24 h after lithium (3 mEq/kg) administration. One minute following pilocarpine injection, HFS (pulses of 60 mus width at 130 Hz at subthreshold intensities and applied during 3 h) was applied alone or combined with subeffective doses of antiepileptic drugs.
HFS alone reduced the incidence of severe generalized seizures. This effect was not evident when HFS was combined with phenytoin (33.3 mg/kg, i.p.). HFS combined with diazepam (0.41 mg/kg, i.p.) or phenobarbital (10 mg/kg, i.p.) reduced the incidence of severe generalized seizures and mortality rate, and augmented the latency to first forelimb clonus, generalized seizure, and status epilepticus (SE). When combined with gabapentin (46 mg/kg, i.p.), HFS reduced the incidence of severe generalized seizures, enhanced latency to SE, and decreased mortality rate.
Subeffective doses of antiepileptic drugs that increase the gamma-aminobutyric acid (GABA)ergic neurotransmission may represent a therapeutic tool to augment the HFS-induced anticonvulsant effects.
评估高频电刺激(HFS)在单独使用以及与亚治疗剂量抗癫痫药物联合使用时对锂-匹罗卡品(LP)诱导的癫痫持续状态(SE)中腹侧海马的影响。
雄性 Wistar 大鼠,在双侧腹侧海马内进行立体定位植入,在锂(3 mEq/kg)给药后 24 小时注射匹罗卡品(30 mg/kg,ip)。在注射匹罗卡品后 1 分钟,单独或联合亚治疗剂量抗癫痫药物应用亚阈强度(60 μs 宽度、130 Hz 的脉冲)的 HFS 3 小时。
单独的 HFS 降低了严重全身性癫痫发作的发生率。当 HFS 与苯妥英(33.3 mg/kg,ip)联合使用时,这种作用不明显。HFS 与地西泮(0.41 mg/kg,ip)或苯巴比妥(10 mg/kg,ip)联合使用可降低严重全身性癫痫发作和死亡率的发生率,并增加首次前肢阵挛、全身性癫痫发作和 SE 的潜伏期。当与加巴喷丁(46 mg/kg,ip)联合使用时,HFS 降低了严重全身性癫痫发作的发生率,增加了 SE 的潜伏期,并降低了死亡率。
增加γ-氨基丁酸(GABA)能神经传递的亚治疗剂量抗癫痫药物可能代表一种增强 HFS 诱导的抗惊厥作用的治疗工具。